Credit Suisse upgraded Eli Lilly (NYSE: LLY) from Neutral to Outperform with a price target of $105.00 (from $89.00).Analyst V ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE